Ardelyx reported $238.02M in Ordinary Share Capital for its fiscal quarter ending in December of 2024.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Amgen USD 538M 300K Sep/2025
Ardelyx USD 238.02M 1.13M Dec/2024
aTyr Pharma USD 97.99M 97.9M Sep/2025
Corcept Therapeutics USD 105.12M 164K Sep/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025
United Therapeutics USD 42.9M 42.1M Sep/2025